NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Pragmatic Trial to Study the Cost-Effectiveness of MyPhenome-RX Test to Guide Anti-Obesity Pharmacotherapy

NCT07728812

Not Yet RecruitingNA

Sponsor: Phenomix Sciences

Conditions: Obesity & Overweight

Interventions: Genetic Test, Anti-Obesity Medication (AOM) treatment

A pragmatic, randomized, parallel-arm, controlled study of weight loss outcomes using AOMs guided by MyPhenome test.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Adults - age 18 or older
* obesity (BMI ≥ 30 kg/m2) without obesity related diseases (ORDs). Or obesity (BMI ≥ 27 kg/m2) with obesity related diseases (ORDs).
* Mayo Clinic employee or dependent
* Referred to Community Internal Medicine Weight Management Program

Exclusion Criteria:

* Pregnancy or currently breast feeding.
* No contraindications to the weight loss medications: Phentermine-Topiramate Extended Release (Qsymia®); Oral naltrexone extended-release/bupropion extended-release (NBSR; Contrave®, Mysimba™); Liraglutide (Saxenda®), Semaglutide (Wegovy®), and Tirzepatide (Zepbound®).